CHRISTINE GEIGER: Open Payments
NPI 1366967614 · DEPEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 44 payments from 10 companies in 2025. Trend: 2023 $137 · 2024 $104 · 2025 $590
Food & beverage: $510Education: $81
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 28 | $226 |
| Regeneron Healthcare Solutions, Inc. | 2 | $104 |
| ABBVIE INC. | 5 | $95 |
| Incyte Corporation | 2 | $46 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Organon LLC | 1 | $21 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
Products named: COSENTYX, DUPIXENT, SKYRIZI, Opzelura, RINVOQ, NEMLUVIO, Rhapsido, VALCHLOR.
Industry payments across NY — which companies pay providers there.
